To improve how patients, providers and research sponsors connect, Epic’s new Life Sciences program is designed to expand clinical trial access to more patients and better support the development of new research.
WHY IT MATTERSThe current disparate systems used for clinical studies can be tedious…
Source: Healthcareitnews.com and Read More
Intravenous (IV) fluids national guidance published
Intravenous (IV) fluid therapy is a complex, high-risk clinical intervention and requires ongoing decision-making throughout the patient journey. This guidance, published by the Australian Commission
